MedTrace Logo

Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic

NCT01179152 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2012-03-19

No results posted yet for this study

Summary

During the second week of September( week 38 of the year)there are recorded data of exacerbation of asthma all over the world, including Israel. A short preventive treatment of 6 weeks may reduce asthma exacerbation in children,reduce primary care and ER visiting and hospitalization.

Conditions

  • Asthma Exacerbation

Interventions

DRUG

Budesonide turbuhaler, Budesonide+Formoterol turbuhaler

Budesonide 200 mcg turbuhaler or Budesonide+Formoterol 160mcg turbuhaler

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Avner He Cohen, Dr · Clalit Health Services

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-10-31
Completion
2012-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01179152 on ClinicalTrials.gov